Although higher serum levels of PDGF in MM patients are thought to be produced from mesothelioma cells and bcl-2 RER is a marker of T cells chronically exposed to asbestos, these may be unknown biological mechanisms between immunocompetent cells with chronic exposure to asbestos and peripheral platelet counts via PDGF. The gene discussed is BCL2; the disease is Miyoshi myopathy.